W. C. Mylander

Finite Algorithms for Solving Quasi-Convex Quadratic Programs

W. C. Mylander, 1971 .

Does breast tumor heterogeneity necessitate further immunohistochemical staining on surgical specimens?

L. Tafra, K. Sawyer, C. Shriver, 2013, Journal of the American College of Surgeons.

Outcomes of Margin Reexcision after Oncoplastic Breast Reduction

L. Tafra, W. C. Mylander, R. Jackson, 2022, Plastic and Reconstructive Surgery, Global Open.

Combined pathologic‐genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay

L. Tafra, A. Raghavendra, A. Sinha, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

A Guide to a SUMT-Version 4 Computer Subroutine for Implementing Sensitivity Analysis in Nonlinear Programming,

Robert L. Armacost, W. Charles Mylander, R. Armacost, 1973 .

A Validated Model for Identifying Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay.

L. Cope, A. Wolff, L. Tafra, 2015, Clinical breast cancer.

RITTER'S CUTTING PLANE METHOD FOR NONCONVEX QUADRATIC PROGRAMMING

R. Cottle, R W Cottle, W C Mylander, 1969 .

A Guide to SUMT-Version 4: The Computer Program Implementing the Sequential Unconstrained Minimization Technique for Nonlinear Programming,

Garth P. McCormick, W. Charles Mylander, Raymond L. Holmes, 1965 .

What is the value of the 21 gene recurrence score in HER2-negative patients?

L. Tafra, M. Rosman, W. C. Mylander, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.